Since spinning off its low-margin infrastructure services into Kyndryl in 2021, IBM has seen its software and consulting segments drive consistent growth. In fiscal 2025, the company booked $9.5 billion in AI-related signings, with approximately 80% coming from consulting engagements that help enterprises implement watsonx-powered solutions and Red Hat OpenShift deployments. Automation and AI now account for roughly 35% of IBM’s software revenue, contributing to a consolidated gross margin of 57.2%. The consulting business returned to growth in Q3, as customers moved pilots into production, and management raised the 2025 free cash flow forecast to $14 billion, implying a price-to-free cash flow ratio near 20x.

IBM continues to push toward commercial quantum advantage. By year-end 2026, the company targets a demonstration of quantum circuits outperforming classical supercomputers. Its Qiskit software platform remains a de facto research standard, optimized for IBM’s superconducting hardware. On the hardware front, IBM plans to deploy its ‘Nighthawk’ chip for early advantage experiments and a fault-tolerant testbed codenamed ‘Loon’, designed to reset failed qubits mid-calculation. Meanwhile, the new z17 mainframe, engineered for AI inference workloads, saw a double-digit unit shipment increase in Q3, underscoring IBM’s hybrid classical–quantum roadmap.

IBM’s quarterly dividend of $1.68 per share yields approximately 2.2%, supported by over a century of uninterrupted payouts and a 30-year streak of annual increases. With a market capitalization of $286 billion and free cash flow projections set to grow as the AI business scales, IBM offers investors a balance of growth exposure and income stability. The company’s disciplined capital allocation, including targeted R&D spending on AI and quantum and routine share repurchases, underpins a prudent risk profile compared to pure-play quantum peers.